What is YK-11? The Scientific Classification
YK-11 is a synthetic steroidal compound that scientists classify as a “gene-selective partial agonist” of the androgen receptor (AR). While many compounds in the research space focus solely on binding to receptors to stimulate growth, YK-11 goes a step further. It is uniquely structured to facilitate follistatin upregulation, which is the biological key to neutralizing the “brake” on muscle growth known as myostatin.
Physical Contents & Research Format:
- Classification: Steroidal S-A-R-M / Myostatin Inhibitor.
- Format: Primarily available as a high-purity research liquid or powder.
- Purity: ≥99% via HPLC validation (The standard at wlaustralia.com.au).
Revolutionize Your Research: The Myostatin Connection
The true “magic” of YK-11 lies in its dual-action mechanism. To understand why this compound is a favorite in the WLA community, we have to look at the triple-threat metabolic pathways it influences:
1. Partial Androgen Agonism
Unlike traditional anabolic agents that may lead to messy, widespread side effects, YK-11 is designed for precision. It binds to the androgen receptor but does not induce the full N/C interaction required for standard transactivation. This means it can drive anabolic gene programs with a “cleaner” profile than traditional alternatives.
2. Follistatin Upregulation
This is where YK-11 truly shines. In research models (specifically C2C12 myoblasts), YK-11 has been shown to significantly increase the expression of follistatin (Fst). Follistatin is a glycoprotein that acts as a natural antagonist to myostatin.
3. Myostatin Inhibition: Breaking the Genetic Ceiling
Myostatin is a protein that serves a singular purpose: to stop your muscles from getting “too big.” It’s a biological governor. By raising follistatin levels, YK-11 effectively silences the myostatin signal. This allows for a level of muscle hypertrophy and cellular differentiation that was previously thought to be restricted by your own genetics.
